Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood vessels are injured. Individuals with hemophilia experience bleeding episodes after injuries and spontaneous bleeding episodes that often lead to joint disease such as arthritis. The most frequent forms of hemophilia affect males.

The global Hemophilia Gene Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

Global Hemophilia Gene Therapy key players include Spark Therapeutics, Ultragenyx, Shire PLC, Sangamo Therapeutics, etc.

This report aims to provide a comprehensive presentation of the global market for Hemophilia Gene Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemophilia Gene Therapy.

Report Scope

The Hemophilia Gene Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemophilia Gene Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hemophilia Gene Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Hemophilia Gene Therapy Market Report

Report Metric	Details
Report Name	Hemophilia Gene Therapy Market
Segment by Type	Hemophilia A Hemophilia B
Segment by Application	Hemophilia A Gene Therapy Hemophilia B Gene Therapy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Spark Therapeutics, Ultragenyx, Shire PLC, Sangamo Therapeutics, Bioverativ, BioMarin, uniQure, Freeline Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hemophilia Gene Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Hemophilia Gene Therapy Market report?

Ans: The main players in the Hemophilia Gene Therapy Market are Spark Therapeutics, Ultragenyx, Shire PLC, Sangamo Therapeutics, Bioverativ, BioMarin, uniQure, Freeline Therapeutics

What are the Application segmentation covered in the Hemophilia Gene Therapy Market report?

Ans: The Applications covered in the Hemophilia Gene Therapy Market report are Hemophilia A Gene Therapy, Hemophilia B Gene Therapy

What are the Type segmentation covered in the Hemophilia Gene Therapy Market report?

Ans: The Types covered in the Hemophilia Gene Therapy Market report are Hemophilia A, Hemophilia B

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Hemophilia Gene Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Hemophilia A

1.2.3 Hemophilia B

1.3 Market by Application

1.3.1 Global Hemophilia Gene Therapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hemophilia A Gene Therapy

1.3.3 Hemophilia B Gene Therapy

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Hemophilia Gene Therapy Market Perspective (2019-2030)

2.2 Hemophilia Gene Therapy Growth Trends by Region

2.2.1 Global Hemophilia Gene Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Hemophilia Gene Therapy Historic Market Size by Region (2019-2024)

2.2.3 Hemophilia Gene Therapy Forecasted Market Size by Region (2025-2030)

2.3 Hemophilia Gene Therapy Market Dynamics

2.3.1 Hemophilia Gene Therapy Industry Trends

2.3.2 Hemophilia Gene Therapy Market Drivers

2.3.3 Hemophilia Gene Therapy Market Challenges

2.3.4 Hemophilia Gene Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Hemophilia Gene Therapy Players by Revenue

3.1.1 Global Top Hemophilia Gene Therapy Players by Revenue (2019-2024)

3.1.2 Global Hemophilia Gene Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Hemophilia Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Hemophilia Gene Therapy Revenue

3.4 Global Hemophilia Gene Therapy Market Concentration Ratio

3.4.1 Global Hemophilia Gene Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Hemophilia Gene Therapy Revenue in 2023

3.5 Hemophilia Gene Therapy Key Players Head office and Area Served

3.6 Key Players Hemophilia Gene Therapy Product Solution and Service

3.7 Date of Enter into Hemophilia Gene Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Hemophilia Gene Therapy Breakdown Data by Type

4.1 Global Hemophilia Gene Therapy Historic Market Size by Type (2019-2024)

4.2 Global Hemophilia Gene Therapy Forecasted Market Size by Type (2025-2030)

5 Hemophilia Gene Therapy Breakdown Data by Application

5.1 Global Hemophilia Gene Therapy Historic Market Size by Application (2019-2024)

5.2 Global Hemophilia Gene Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Hemophilia Gene Therapy Market Size (2019-2030)

6.2 North America Hemophilia Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Hemophilia Gene Therapy Market Size by Country (2019-2024)

6.4 North America Hemophilia Gene Therapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Hemophilia Gene Therapy Market Size (2019-2030)

7.2 Europe Hemophilia Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Hemophilia Gene Therapy Market Size by Country (2019-2024)

7.4 Europe Hemophilia Gene Therapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Hemophilia Gene Therapy Market Size (2019-2030)

8.2 Asia-Pacific Hemophilia Gene Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Hemophilia Gene Therapy Market Size by Region (2019-2024)

8.4 Asia-Pacific Hemophilia Gene Therapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Hemophilia Gene Therapy Market Size (2019-2030)

9.2 Latin America Hemophilia Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Hemophilia Gene Therapy Market Size by Country (2019-2024)

9.4 Latin America Hemophilia Gene Therapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Hemophilia Gene Therapy Market Size (2019-2030)

10.2 Middle East & Africa Hemophilia Gene Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Hemophilia Gene Therapy Market Size by Country (2019-2024)

10.4 Middle East & Africa Hemophilia Gene Therapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Spark Therapeutics

11.1.1 Spark Therapeutics Company Detail

11.1.2 Spark Therapeutics Business Overview

11.1.3 Spark Therapeutics Hemophilia Gene Therapy Introduction

11.1.4 Spark Therapeutics Revenue in Hemophilia Gene Therapy Business (2019-2024)

11.1.5 Spark Therapeutics Recent Development

11.2 Ultragenyx

11.2.1 Ultragenyx Company Detail

11.2.2 Ultragenyx Business Overview

11.2.3 Ultragenyx Hemophilia Gene Therapy Introduction

11.2.4 Ultragenyx Revenue in Hemophilia Gene Therapy Business (2019-2024)

11.2.5 Ultragenyx Recent Development

11.3 Shire PLC

11.3.1 Shire PLC Company Detail

11.3.2 Shire PLC Business Overview

11.3.3 Shire PLC Hemophilia Gene Therapy Introduction

11.3.4 Shire PLC Revenue in Hemophilia Gene Therapy Business (2019-2024)

11.3.5 Shire PLC Recent Development

11.4 Sangamo Therapeutics

11.4.1 Sangamo Therapeutics Company Detail

11.4.2 Sangamo Therapeutics Business Overview

11.4.3 Sangamo Therapeutics Hemophilia Gene Therapy Introduction

11.4.4 Sangamo Therapeutics Revenue in Hemophilia Gene Therapy Business (2019-2024)

11.4.5 Sangamo Therapeutics Recent Development

11.5 Bioverativ

11.5.1 Bioverativ Company Detail

11.5.2 Bioverativ Business Overview

11.5.3 Bioverativ Hemophilia Gene Therapy Introduction

11.5.4 Bioverativ Revenue in Hemophilia Gene Therapy Business (2019-2024)

11.5.5 Bioverativ Recent Development

11.6 BioMarin

11.6.1 BioMarin Company Detail

11.6.2 BioMarin Business Overview

11.6.3 BioMarin Hemophilia Gene Therapy Introduction

11.6.4 BioMarin Revenue in Hemophilia Gene Therapy Business (2019-2024)

11.6.5 BioMarin Recent Development

11.7 uniQure

11.7.1 uniQure Company Detail

11.7.2 uniQure Business Overview

11.7.3 uniQure Hemophilia Gene Therapy Introduction

11.7.4 uniQure Revenue in Hemophilia Gene Therapy Business (2019-2024)

11.7.5 uniQure Recent Development

11.8 Freeline Therapeutics

11.8.1 Freeline Therapeutics Company Detail

11.8.2 Freeline Therapeutics Business Overview

11.8.3 Freeline Therapeutics Hemophilia Gene Therapy Introduction

11.8.4 Freeline Therapeutics Revenue in Hemophilia Gene Therapy Business (2019-2024)

11.8.5 Freeline Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Freeline Therapeutics

List of Tables

Table 1. Global Hemophilia Gene Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Hemophilia A

Table 3. Key Players of Hemophilia B

Table 4. Global Hemophilia Gene Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Hemophilia Gene Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Hemophilia Gene Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Hemophilia Gene Therapy Market Share by Region (2019-2024)

Table 8. Global Hemophilia Gene Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Hemophilia Gene Therapy Market Share by Region (2025-2030)

Table 10. Hemophilia Gene Therapy Market Trends

Table 11. Hemophilia Gene Therapy Market Drivers

Table 12. Hemophilia Gene Therapy Market Challenges

Table 13. Hemophilia Gene Therapy Market Restraints

Table 14. Global Hemophilia Gene Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Hemophilia Gene Therapy Market Share by Players (2019-2024)

Table 16. Global Top Hemophilia Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophilia Gene Therapy as of 2023)

Table 17. Ranking of Global Top Hemophilia Gene Therapy Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Hemophilia Gene Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Hemophilia Gene Therapy Product Solution and Service

Table 21. Date of Enter into Hemophilia Gene Therapy Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Hemophilia Gene Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Hemophilia Gene Therapy Revenue Market Share by Type (2019-2024)

Table 25. Global Hemophilia Gene Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Hemophilia Gene Therapy Revenue Market Share by Type (2025-2030)

Table 27. Global Hemophilia Gene Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Hemophilia Gene Therapy Revenue Market Share by Application (2019-2024)

Table 29. Global Hemophilia Gene Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Hemophilia Gene Therapy Revenue Market Share by Application (2025-2030)

Table 31. North America Hemophilia Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Hemophilia Gene Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Hemophilia Gene Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Hemophilia Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Hemophilia Gene Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Hemophilia Gene Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Hemophilia Gene Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Hemophilia Gene Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Hemophilia Gene Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Hemophilia Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Hemophilia Gene Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Hemophilia Gene Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Hemophilia Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Hemophilia Gene Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Hemophilia Gene Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 46. Spark Therapeutics Company Detail

Table 47. Spark Therapeutics Business Overview

Table 48. Spark Therapeutics Hemophilia Gene Therapy Product

Table 49. Spark Therapeutics Revenue in Hemophilia Gene Therapy Business (2019-2024) & (US$ Million)

Table 50. Spark Therapeutics Recent Development

Table 51. Ultragenyx Company Detail

Table 52. Ultragenyx Business Overview

Table 53. Ultragenyx Hemophilia Gene Therapy Product

Table 54. Ultragenyx Revenue in Hemophilia Gene Therapy Business (2019-2024) & (US$ Million)

Table 55. Ultragenyx Recent Development

Table 56. Shire PLC Company Detail

Table 57. Shire PLC Business Overview

Table 58. Shire PLC Hemophilia Gene Therapy Product

Table 59. Shire PLC Revenue in Hemophilia Gene Therapy Business (2019-2024) & (US$ Million)

Table 60. Shire PLC Recent Development

Table 61. Sangamo Therapeutics Company Detail

Table 62. Sangamo Therapeutics Business Overview

Table 63. Sangamo Therapeutics Hemophilia Gene Therapy Product

Table 64. Sangamo Therapeutics Revenue in Hemophilia Gene Therapy Business (2019-2024) & (US$ Million)

Table 65. Sangamo Therapeutics Recent Development

Table 66. Bioverativ Company Detail

Table 67. Bioverativ Business Overview

Table 68. Bioverativ Hemophilia Gene Therapy Product

Table 69. Bioverativ Revenue in Hemophilia Gene Therapy Business (2019-2024) & (US$ Million)

Table 70. Bioverativ Recent Development

Table 71. BioMarin Company Detail

Table 72. BioMarin Business Overview

Table 73. BioMarin Hemophilia Gene Therapy Product

Table 74. BioMarin Revenue in Hemophilia Gene Therapy Business (2019-2024) & (US$ Million)

Table 75. BioMarin Recent Development

Table 76. uniQure Company Detail

Table 77. uniQure Business Overview

Table 78. uniQure Hemophilia Gene Therapy Product

Table 79. uniQure Revenue in Hemophilia Gene Therapy Business (2019-2024) & (US$ Million)

Table 80. uniQure Recent Development

Table 81. Freeline Therapeutics Company Detail

Table 82. Freeline Therapeutics Business Overview

Table 83. Freeline Therapeutics Hemophilia Gene Therapy Product

Table 84. Freeline Therapeutics Revenue in Hemophilia Gene Therapy Business (2019-2024) & (US$ Million)

Table 85. Freeline Therapeutics Recent Development

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Hemophilia Gene Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Hemophilia Gene Therapy Market Share by Type: 2023 VS 2030

Figure 3. Hemophilia A Features

Figure 4. Hemophilia B Features

Figure 5. Global Hemophilia Gene Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Hemophilia Gene Therapy Market Share by Application: 2023 VS 2030

Figure 7. Hemophilia A Gene Therapy Case Studies

Figure 8. Hemophilia B Gene Therapy Case Studies

Figure 9. Hemophilia Gene Therapy Report Years Considered

Figure 10. Global Hemophilia Gene Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 11. Global Hemophilia Gene Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Hemophilia Gene Therapy Market Share by Region: 2023 VS 2030

Figure 13. Global Hemophilia Gene Therapy Market Share by Players in 2023

Figure 14. Global Top Hemophilia Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophilia Gene Therapy as of 2023)

Figure 15. The Top 10 and 5 Players Market Share by Hemophilia Gene Therapy Revenue in 2023

Figure 16. North America Hemophilia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 17. North America Hemophilia Gene Therapy Market Share by Country (2019-2030)

Figure 18. United States Hemophilia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. Canada Hemophilia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Europe Hemophilia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Hemophilia Gene Therapy Market Share by Country (2019-2030)

Figure 22. Germany Hemophilia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. France Hemophilia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. U.K. Hemophilia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Italy Hemophilia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Russia Hemophilia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Nordic Countries Hemophilia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Asia-Pacific Hemophilia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Hemophilia Gene Therapy Market Share by Region (2019-2030)

Figure 30. China Hemophilia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Japan Hemophilia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. South Korea Hemophilia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Southeast Asia Hemophilia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. India Hemophilia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Australia Hemophilia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Latin America Hemophilia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Hemophilia Gene Therapy Market Share by Country (2019-2030)

Figure 38. Mexico Hemophilia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Brazil Hemophilia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Middle East & Africa Hemophilia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Hemophilia Gene Therapy Market Share by Country (2019-2030)

Figure 42. Turkey Hemophilia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Saudi Arabia Hemophilia Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Spark Therapeutics Revenue Growth Rate in Hemophilia Gene Therapy Business (2019-2024)

Figure 45. Ultragenyx Revenue Growth Rate in Hemophilia Gene Therapy Business (2019-2024)

Figure 46. Shire PLC Revenue Growth Rate in Hemophilia Gene Therapy Business (2019-2024)

Figure 47. Sangamo Therapeutics Revenue Growth Rate in Hemophilia Gene Therapy Business (2019-2024)

Figure 48. Bioverativ Revenue Growth Rate in Hemophilia Gene Therapy Business (2019-2024)

Figure 49. BioMarin Revenue Growth Rate in Hemophilia Gene Therapy Business (2019-2024)

Figure 50. uniQure Revenue Growth Rate in Hemophilia Gene Therapy Business (2019-2024)

Figure 51. Freeline Therapeutics Revenue Growth Rate in Hemophilia Gene Therapy Business (2019-2024)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-24R5886

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Congenital Heart Diseases Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-29D6035

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Gardner Syndrome Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-28H13051

Tue Mar 26 00:00:00 UTC 2024

Add to Cart

Drugs for Alport Syndrome - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-16A13427

Tue Mar 26 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Hemophilia Gene Therapy Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-13B13011

Global Hemophilia Gene Therapy Market Research Report 2024

FEATURED COMPANIES

Hemophilia Gene Therapy Market

Report Scope

Scope of Hemophilia Gene Therapy Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Hemophilia Gene Therapy Market report?

What are the Application segmentation covered in the Hemophilia Gene Therapy Market report?

What are the Type segmentation covered in the Hemophilia Gene Therapy Market report?

FEATURED COMPANIES

RELATED REPORTS